DNAL1 and neoplasm: More recently, Marcinkowski et al. identified a KK-LC-1 reactive T cell receptor from tumor infiltrating lymphocytes (TIL) in a patient with cervical cancer who had a subsequent complete tumor response to TIL therapy [10].